Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
INV-DEN-104
Phase 1 mab completed
Quick answer
Takeda's Tetravalent Dengue Vaccine Candidate (TDV) for Healthy is a Phase 1 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Healthy
- Phase
- Phase 1
- Modality
- mab
- Status
- completed